| pubmed-article:20595511 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20595511 | lifeskim:mentions | umls-concept:C0031268 | lld:lifeskim |
| pubmed-article:20595511 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:20595511 | lifeskim:mentions | umls-concept:C0182638 | lld:lifeskim |
| pubmed-article:20595511 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:20595511 | lifeskim:mentions | umls-concept:C0040399 | lld:lifeskim |
| pubmed-article:20595511 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:20595511 | pubmed:dateCreated | 2010-7-2 | lld:pubmed |
| pubmed-article:20595511 | pubmed:abstractText | Strong overexpression of glucagonlike peptide-1 (GLP-1) receptors in human insulinoma provides an attractive target for imaging. The first clinical trials demonstrated that GLP-1 receptor SPECT/CT using [Lys(40)(Ahx [6-aminohexanoic acid]-DOTA-(111)In)NH(2)]-exendin-4 can localize hardly detectable insulinomas. However, [Lys(40)(Ahx-DOTA-(111)In)NH(2)]-exendin-4 imaging has drawbacks related to the use of (111)In in that it is costly and carries a relatively high radiation burden for the patient. The aim of this study was the preclinical evaluation of [Lys(40)(Ahx-DOTA-(68)Ga)NH(2)]-exendin-4 for PET/CT and [Lys(40)(Ahx-hydrazinonicotinamide [HYNIC]-(99m)Tc)NH(2)]-exendin-4 for SPECT/CT. | lld:pubmed |
| pubmed-article:20595511 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20595511 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20595511 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20595511 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20595511 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20595511 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20595511 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20595511 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20595511 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20595511 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20595511 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20595511 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20595511 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20595511 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20595511 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:20595511 | pubmed:issn | 1535-5667 | lld:pubmed |
| pubmed-article:20595511 | pubmed:author | pubmed-author:ChristoforiGe... | lld:pubmed |
| pubmed-article:20595511 | pubmed:author | pubmed-author:EllPeter JPJ | lld:pubmed |
| pubmed-article:20595511 | pubmed:author | pubmed-author:BéhéMartinM | lld:pubmed |
| pubmed-article:20595511 | pubmed:author | pubmed-author:MäckeHelmut... | lld:pubmed |
| pubmed-article:20595511 | pubmed:author | pubmed-author:WickiAndreasA | lld:pubmed |
| pubmed-article:20595511 | pubmed:author | pubmed-author:BernhardtPete... | lld:pubmed |
| pubmed-article:20595511 | pubmed:author | pubmed-author:WildDamianD | lld:pubmed |
| pubmed-article:20595511 | pubmed:author | pubmed-author:KeilBorisB | lld:pubmed |
| pubmed-article:20595511 | pubmed:author | pubmed-author:MansiRosalbaR | lld:pubmed |
| pubmed-article:20595511 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20595511 | pubmed:volume | 51 | lld:pubmed |
| pubmed-article:20595511 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20595511 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20595511 | pubmed:pagination | 1059-67 | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:meshHeading | pubmed-meshheading:20595511... | lld:pubmed |
| pubmed-article:20595511 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20595511 | pubmed:articleTitle | Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT. | lld:pubmed |
| pubmed-article:20595511 | pubmed:affiliation | Clinic and Institute of Nuclear Medicine, University Hospital Basel, Basel, Switzerland. | lld:pubmed |
| pubmed-article:20595511 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20595511 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
